Maximizing the Post-Approval Safety of Flibanserin: A Role for Regulators, Clinicians, and Patients

Drug Safety : an International Journal of Medical Toxicology and Drug Experience
Sheriza N BakshG Caleb Alexander

Abstract

In August 2015, the US Food and Drug Administration (FDA) made the controversial decision to approve flibanserin (Addyi®) for women experiencing hypoactive sexual desire disorder. A number of factors contributed to disagreements regarding the FDA's decision, including the product's two prior failed FDA reviews, the unmet need of women with this disorder, extensive advocacy and politicization surrounding the product's relevance to women and sexual health, the potential for widespread off-label use, and the product's tenuous risk/benefit profile. Despite that, attention now shifts to maximizing the safe use of the product, including the optimal means to avoid numerous drug-drug interactions as well as the concomitant use of alcohol, both of which potentiate the risks of dizziness, hypotension, and syncope. Although the FDA has implemented a comprehensive Risk Evaluation and Mitigation Strategies program to maximize the product's safe use, patients, clinicians, and regulators must exhibit heightened vigilance early in the product's post-market life.

References

Sep 2, 1998·British Journal of Clinical Pharmacology·D G BaileyJ D Spence
May 29, 2000·Clinical Pharmacology and Therapeutics·C A RobyA H Burstein
Apr 12, 2006·Menopause : the Journal of the North American Menopause Society·Sandra R LeiblumRaymond C Rosen
Dec 26, 2008·JAMA : the Journal of the American Medical Association·Dima M QatoStacy Tessler Lindau
Sep 25, 2009·Archives of Sexual Behavior·Lori A Brotto
Oct 13, 2011·JAMA : the Journal of the American Medical Association·Dima M Qato, G Caleb Alexander
Jan 14, 2012·The Journal of Sexual Medicine·John ThorpUNKNOWN DAISY trial investigators
Jan 18, 2012·The Journal of Sexual Medicine·Leonard R DerogatisUNKNOWN VIOLET Trial Investigators
Sep 27, 2012·American Journal of Therapeutics·Kenneth A GetzKenneth I Kaitin
Apr 6, 2013·Archives of Sexual Behavior·Sarah FrühaufJürgen Barth
May 16, 2013·The Journal of Sexual Medicine·Molly KatzUNKNOWN BEGONIA trial investigators
Jul 7, 2015·JAMA : the Journal of the American Medical Association·Walid F GelladG Caleb Alexander
Dec 10, 2015·The New England Journal of Medicine·Hylton V JoffeJulie Beitz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.